Literature DB >> 24412755

Pyridinyl imidazole compounds interfere with melanosomes sorting through the inhibition of cyclin G-associated Kinase, a regulator of cathepsins maturation.

Barbara Bellei1, Angela Pitisci2, Emilia Migliano3, Giorgia Cardinali2, Mauro Picardo2.   

Abstract

Transfer of melanin-containing melanosomes from melanocytes to neighboring keratinocytes results in skin pigmentation. Pharmacological modulation of melanosomal transfer has recently gained much attention as a strategy for modifying normal or abnormal pigmentation. In this study, while investigating the impact of pyridinyl imidazole (PI) compounds, a class of p38 MAPK inhibitors, on melanocyte differentiation we observed that some, but not all PIs interfere with the physiological melanosome sorting producing a strong retention of melanin in the intracellular compartment associated with a general reduction of melanin synthesis. Electron microscopy studies illustrated an accumulation of melanosomes inside melanocytes with enrichment in immature melanosome at stages II and III at the end of dendrites. We identified cyclin G-associated kinase GAK, a protein expressed ubiquitously in various tissues, as the off-target responsible of intracellular melanin accumulation and we report evidence that reduced GAK-dependent cathepsin maturation is implicated in melanosome sorting deficiency. The co-regulation of GAK and cathepsin B and L expression with the melanogenic biosynthetic pathway in normal human melanocytes as well as in B16-F0 melanoma cells strengthen the idea that these proteins represent new possible targets for prevention and treatment of irregular pigmentation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cathepsin; GAK; MAP Kinases; Melanosomes; Pigmentation; Pyridinyl imidazole compounds

Mesh:

Substances:

Year:  2014        PMID: 24412755     DOI: 10.1016/j.cellsig.2013.12.023

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  4 in total

1.  Melanoma miRNA trafficking controls tumour primary niche formation.

Authors:  Shani Dror; Laureen Sander; Hila Schwartz; Danna Sheinboim; Aviv Barzilai; Yuval Dishon; Sebastien Apcher; Tamar Golan; Shoshana Greenberger; Iris Barshack; Hagar Malcov; Alona Zilberberg; Lotan Levin; Michelle Nessling; Yael Friedmann; Vivien Igras; Ohad Barzilay; Hananya Vaknine; Ronen Brenner; Assaf Zinger; Avi Schroeder; Pinchas Gonen; Mehdi Khaled; Neta Erez; Jörg D Hoheisel; Carmit Levy
Journal:  Nat Cell Biol       Date:  2016-08-22       Impact factor: 28.824

2.  Identification and Optimization of 4-Anilinoquinolines as Inhibitors of Cyclin G Associated Kinase.

Authors:  Christopher R M Asquith; Tuomo Laitinen; James M Bennett; Paulo H Godoi; Michael P East; Graham J Tizzard; Lee M Graves; Gary L Johnson; Ronna E Dornsife; Carrow I Wells; Jonathan M Elkins; Timothy M Willson; William J Zuercher
Journal:  ChemMedChem       Date:  2017-11-27       Impact factor: 3.466

3.  Selective Inhibitors of Cyclin G Associated Kinase (GAK) as Anti-Hepatitis C Agents.

Authors:  Sona Kovackova; Lei Chang; Elena Bekerman; Gregory Neveu; Rina Barouch-Bentov; Apirat Chaikuad; Christina Heroven; Michal Šála; Steven De Jonghe; Stefan Knapp; Shirit Einav; Piet Herdewijn
Journal:  J Med Chem       Date:  2015-04-09       Impact factor: 7.446

4.  Dual Targeting of BRAF and mTOR Signaling in Melanoma Cells with Pyridinyl Imidazole Compounds.

Authors:  Veronika Palušová; Tereza Renzová; Amandine Verlande; Tereza Vaclová; Michaela Medková; Linda Cetlová; Miroslava Sedláčková; Hana Hříbková; Iva Slaninová; Miriama Krutá; Vladimír Rotrekl; Hana Uhlířová; Aneta Křížová; Radim Chmelík; Pavel Veselý; Michaela Krafčíková; Lukáš Trantírek; Kay Oliver Schink; Stjepan Uldrijan
Journal:  Cancers (Basel)       Date:  2020-06-10       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.